Welcome to our dedicated page for U S Physical Therapy news (Ticker: USPH), a resource for investors and traders seeking the latest updates and insights on U S Physical Therapy stock.
U.S. Physical Therapy reports recurring developments tied to its national outpatient physical therapy clinic network and industrial injury prevention services business. Company news commonly covers physical therapy revenue, mature-clinic activity, gross profit, reimbursement-sensitive care categories, and services for orthopedic conditions, sports injuries, neurological injuries, post-operative care, preventative care, and injured-worker rehabilitation.
Updates also include acquisitions of clinic practices and industrial injury prevention businesses, hospital and regional care alliances, investor presentations, dividends, share repurchases, and credit facility changes. Its industrial injury prevention services include onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments for client workforces.
U.S. Physical Therapy (NYSE:USPH) reported full-year 2025 results with Adjusted EBITDA of $95.0 million (up 16.2%) and USPH net income $39.6 million. Fourth-quarter net revenue from physical therapy operations rose 13.0% to $173.8 million and total patient visits increased 11.2% to 1,593,336.
The Board raised the quarterly dividend to $0.46 and management guided 2026 Adjusted EBITDA to $102.0–$106.0 million. Recent acquisitions and multi-year hospital alliances were announced to expand clinic reach and IIP services.
U.S. Physical Therapy (NYSE: USPH) will report fourth-quarter and full-year 2025 results on Wednesday, February 25, 2026 after market close, with a conference call scheduled for Thursday, February 26, 2026 at 10:30 AM ET.
Investors can join by dialing the provided numbers with Conference ID USPHQ425 or listen via webcast at www.usph.com. A replay will be available through May 27, 2026.
U.S. Physical Therapy (NYSE: USPH) announced the acquisition of an industrial injury prevention business for approximately $15.1 million on February 2, 2026. USPH acquired a 70% interest while the seller retained 30%. The acquired business currently generates about $7.0 million in annual revenues. USPH said the deal expands its industrial injury prevention service lines and presents cross-selling opportunities with existing partners.
U.S. Physical Therapy (NYSE:USPH) announced a 10-year strategic alliance between its subsidiary Metro Physical & Aquatic Therapy and NYU Langone Health to integrate Metro’s existing 60 outpatient clinics into NYU Langone’s clinical services network in Long Island and the New York metro area. The alliance is expected to become operational within the next few months. USPH said it will disclose financial impacts on its year-end earnings release and conference call scheduled for February 25–26, 2026.
U.S. Physical Therapy (NYSE:USPH) announced that CEO Chris Reading presented at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026. The company operates 780 outpatient physical therapy clinics in 44 states and offers industrial injury prevention services including onsite injury prevention, rehabilitation, performance optimization, post-offer testing, functional capacity evaluations, and ergonomic assessments.
Contact details for investor inquiries include CFO Carey Hendrickson (Email: Chendrickson@usph.com) and CEO Chris Reading (Phone: (713) 297-7000).
U.S. Physical Therapy (NYSE:USPH) announced on January 5, 2026 the acquisition of a physical therapy management services company that operates eight clinics, generating approximately $8.0 million in annual revenues and 66,000 annual visits. USPH acquired a 50% interest while the current owners retained the remaining 50% ownership. The acquired practice will continue operating under the existing management partnership model and expand USPH's outpatient and occupational health services.
Company scale: USPH owns and/or manages 780 outpatient clinics across 44 states.
U.S. Physical Therapy (NYSE:USPH) reported results for the quarter ended September 30, 2025, with total net revenue up 17.8% to $168.1M and Adjusted EBITDA of $23.9M (up 13.2% year‑over‑year). Net income attributable to USPH shareholders was $13.1M and diluted EPS was $0.48 for the 2025 third quarter.
Physical therapy operations visits rose 18.0% to 1,554,207 visits and average daily visits per clinic hit a third‑quarter record of 32.2. IIP revenue grew 14.6% to $29.0M. The company added a net 79 clinics year‑over‑year to reach 779 clinics and reaffirmed full‑year 2025 Adjusted EBITDA guidance of $93.0M–$97.0M. The Board declared a $0.45 quarterly dividend payable Dec 12, 2025.
U.S. Physical Therapy (NYSE: USPH) will report results for the three and nine months ended September 30, 2025 on Wednesday, November 5, 2025 after market close. The company will host a conference call the next morning on Thursday, November 6, 2025 at 10:30 AM Eastern / 9:30 AM Central.
Dial-in numbers are (800) 245-3047 (primary) and (203) 518-9765 (alternate) using Conference ID USPHQ325. A live webcast will be available at www.usph.com under Investor Relations, and a replay will remain available through February 4, 2026.
U.S. Physical Therapy (NYSE: USPH), a leading national operator of outpatient physical therapy clinics, announced its CFO Carey Hendrickson's participation in the Jefferies Healthcare Services Conference on September 30, 2025.
The company operates 781 outpatient physical therapy clinics across 44 states, providing services including preventative care, post-operative care for orthopedic disorders, sports injury treatment, and neurological injury rehabilitation. Additionally, USPH maintains an industrial injury prevention business offering onsite services such as injury prevention, performance optimization, and ergonomic assessments.
U.S. Physical Therapy (NYSE:USPH) reported strong Q2 2025 results with record patient visits and raised full-year guidance. The company achieved Adjusted EBITDA of $26.9 million, up 21.4% year-over-year, and net income of $12.4 million compared to $7.5 million in Q2 2024.
Key highlights include total revenue growth of 17.3% to $168.3 million in physical therapy operations and 22.6% growth in industrial injury prevention services to $29.1 million. The company recorded an all-time high of 32.7 average daily patient visits per clinic and expanded its network to 768 clinics. USPH completed two strategic acquisitions and declared a quarterly dividend of $0.45 per share.
Management increased 2025 Adjusted EBITDA guidance to $93.0-97.0 million, reflecting strong operational performance despite a 2.9% Medicare rate reduction.